Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells
Read article
News
All
New York startup raises $33M for fertility treatment based on George Church’s stem cell research
Read article
News
All
Gameto Announces Patient Experience Data Demonstrating Investigational In Vitro Maturation Solution Well Tolerated with Higher Patient Satisfaction Rates than Conventional Fertility Stimulation
